- Datum03.02.2026
- Uhrzeit12:00 - 13:00 Uhr
- Veranstalter
stock3
TransMedics Group Inc. Chart inkl. Chartanalyse
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
TransMedics Group Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate BSX | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-1,19 %
Intraday
-4,88 %
1 Woche
6,38 %
1 Monat
12,10 %
Seit Jahresbeginn
118,03 %
1 Jahr
106,44 %
3 Jahre
473,73 %
5 Jahre
Passender Service zu TransMedics Group Inc.
Webinar zu TransMedics Group Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)58,540-156,000
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von TransMedics Group Inc.
Keine Dividenden verfügbar
Termine von TransMedics Group Inc.
- Mär4TransMedics Group Inc.Q4 2025 Earnings Release
- Mai5TransMedics Group Inc.Q1 2026 Earnings Release
- Jul30TransMedics Group Inc.Q2 2026 Earnings Release
Beschreibung
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
